Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Idrugs : the Investigational Drugs Journal
|
May 10, 2008
Rifalazil(Kaneka corp)
M Pregnolato
Farmaco (Societa Chimica Italiana : 1989)
|
November 27, 1999
Antimicrobial and genotoxic activities of N-(2-hydroxyethyl)-1,2-benzisothiazol-3(2H)-thione carbamic esters
F Zani, M Pregnolato, F Zampollo
The Science of the Total Environment
|
March 8, 2019
Preparedness against mobility disruption by floods
C Arrighi, M Pregnolato, R J Dawson, et al.
Antimicrobial Agents and Chemotherapy
|
April 19, 2000
Selective interaction of the human immunodeficiency virus type 1 reverse transcriptase nonnucleoside inhibitor efavirenz and its thio-substituted analog with different enzyme-substrate complexes
G Maga, D Ubiali, R Salvetti, et al.
Archiv Der Pharmazie
|
August 1, 1996
In vitro anti-Mycobacterium avium activity of N-(2-hydroxyethyl)-1,2-benzisothiazol-3(2H)-one and -thione carbamic esters
G Pagani, P Borgna, C Piersimoni, et al.
Journal of Chromatography. A
|
November 12, 1998
Deuterated internal standards for gas chromatographic-mass spectrometric analysis of polar organophosphorus pesticides in water samples
P Grasso, E Benfenati, M Terreni, et al.
Antimicrobial Agents and Chemotherapy
|
March 21, 2001
Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and d- and L-(beta)-dideoxynucleoside triphosphate analogs
G Maga, U Hübscher, M Pregnolato, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
February 24, 2001
3H-[1,2]Dithiolo[3,4-b]pyridine-3-thione and its derivatives synthesis and antimicrobial activity
M Pregnolato, M Terreni, D Ubiali, et al.
Journal of Medicinal Chemistry
|
July 13, 2000
Novel nonsubstrate inhibitors of human thymidine phosphorylase, a potential target for tumor-dependent angiogenesis
F Focher, D Ubiali, M Pregnolato, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1993
Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation
M B Regazzi, F Locatelli, I Buggia, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Idrugs : the Investigational Drugs Journal
|
May 10, 2008
Rifalazil(Kaneka corp)
M Pregnolato
Farmaco (Societa Chimica Italiana : 1989)
|
November 27, 1999
Antimicrobial and genotoxic activities of N-(2-hydroxyethyl)-1,2-benzisothiazol-3(2H)-thione carbamic esters
F Zani, M Pregnolato, F Zampollo
The Science of the Total Environment
|
March 8, 2019
Preparedness against mobility disruption by floods
C Arrighi, M Pregnolato, R J Dawson, et al.
Antimicrobial Agents and Chemotherapy
|
April 19, 2000
Selective interaction of the human immunodeficiency virus type 1 reverse transcriptase nonnucleoside inhibitor efavirenz and its thio-substituted analog with different enzyme-substrate complexes
G Maga, D Ubiali, R Salvetti, et al.
Archiv Der Pharmazie
|
August 1, 1996
In vitro anti-Mycobacterium avium activity of N-(2-hydroxyethyl)-1,2-benzisothiazol-3(2H)-one and -thione carbamic esters
G Pagani, P Borgna, C Piersimoni, et al.
Journal of Chromatography. A
|
November 12, 1998
Deuterated internal standards for gas chromatographic-mass spectrometric analysis of polar organophosphorus pesticides in water samples
P Grasso, E Benfenati, M Terreni, et al.
Antimicrobial Agents and Chemotherapy
|
March 21, 2001
Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and d- and L-(beta)-dideoxynucleoside triphosphate analogs
G Maga, U Hübscher, M Pregnolato, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
February 24, 2001
3H-[1,2]Dithiolo[3,4-b]pyridine-3-thione and its derivatives synthesis and antimicrobial activity
M Pregnolato, M Terreni, D Ubiali, et al.
Journal of Medicinal Chemistry
|
July 13, 2000
Novel nonsubstrate inhibitors of human thymidine phosphorylase, a potential target for tumor-dependent angiogenesis
F Focher, D Ubiali, M Pregnolato, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1993
Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation
M B Regazzi, F Locatelli, I Buggia, et al.
Page
of 2